Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


LAGE-1, a new gene with tumor specificity.

Lethé B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E, Boon T.

Int J Cancer. 1998 Jun 10;76(6):903-8.


NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.

Bolli M, Schultz-Thater E, Zajac P, Guller U, Feder C, Sanguedolce F, Carafa V, Terracciano L, Hudolin T, Spagnoli GC, Tornillo L.

Int J Cancer. 2005 Jul 20;115(6):960-6.


Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J.

Clin Cancer Res. 2004 Dec 15;10(24):8396-404.


The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells.

Mandic M, Almunia C, Vicel S, Gillet D, Janjic B, Coval K, Maillere B, Kirkwood JM, Zarour HM.

Cancer Res. 2003 Oct 1;63(19):6506-15.


Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.

Rimoldi D, Rubio-Godoy V, Dutoit V, Lienard D, Salvi S, Guillaume P, Speiser D, Stockert E, Spagnoli G, Servis C, Cerottini JC, Lejeune F, Romero P, Valmori D.

J Immunol. 2000 Dec 15;165(12):7253-61.


Identification on a human sarcoma of two new genes with tumor-specific expression.

Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T.

Cancer Res. 2000 Jul 15;60(14):3848-55.


A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray.

Kan T, Yamasaki S, Kondo K, Teratani N, Kawabe A, Kaganoi J, Meltzer SJ, Imamura M, Shimada Y.

Oncology. 2006;70(1):25-33. Epub 2006 Jan 27.


Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library.

Chen YT, Güre AO, Tsang S, Stockert E, Jäger E, Knuth A, Old LJ.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6919-23.


A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved.

Alpen B, Güre AO, Scanlan MJ, Old LJ, Chen YT.

Gene. 2002 Sep 4;297(1-2):141-9.


NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ.

Cancer Res. 2003 Sep 15;63(18):6076-83.


Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.

Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ.

Cancer Immun. 2003 Dec 18;3:19.


Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1.

Kudela P, Sun Z, Fourcade J, Janjic B, Kirkwood JM, Maillere B, Zarour HM.

J Immunol. 2011 Jan 1;186(1):312-22. doi: 10.4049/jimmunol.1001989. Epub 2010 Dec 3.


CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.

Slager EH, Borghi M, van der Minne CE, Aarnoudse CA, Havenga MJ, Schrier PI, Osanto S, Griffioen M.

J Immunol. 2003 Feb 1;170(3):1490-7.


[Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma].

Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y, Wen JM.

Zhonghua Bing Li Xue Za Zhi. 2005 Apr;34(4):202-5. Chinese.


Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.

Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, Inoue H, Sugimachi K, Mori M.

Br J Cancer. 2001 Sep 1;85(5):713-20.


Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.

Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E.

Int J Oncol. 2005 Jan;26(1):57-63.


NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.

Pollack SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU 3rd, Jones RL, Yee C.

PLoS One. 2012;7(2):e32165. doi: 10.1371/journal.pone.0032165. Epub 2012 Feb 27.


Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.

McCormack E, Adams KJ, Hassan NJ, Kotian A, Lissin NM, Sami M, Mujić M, Osdal T, Gjertsen BT, Baker D, Powlesland AS, Aleksic M, Vuidepot A, Morteau O, Sutton DH, June CH, Kalos M, Ashfield R, Jakobsen BK.

Cancer Immunol Immunother. 2013 Apr;62(4):773-85. doi: 10.1007/s00262-012-1384-4. Epub 2012 Dec 22.


Identification of a new MAGE gene with tumor-specific expression by representational difference analysis.

Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, Lurquin C, Boon T.

Cancer Res. 1998 Feb 15;58(4):743-52.


Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.

Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J.

Clin Cancer Res. 2005 Mar 1;11(5):1809-14.

Supplemental Content

Support Center